The study emphasizes changes in the health of bladder and urinary tract in the entire menopause

The menopause crossing is often accompanied by a variety of symptoms, some of which receive more attention than others. Problems with bladder health and in the lower urinary trouble problems are examples of not well -examined topics. A new study focused on the association of menopaus status and the use of hormones with bladder and urinary tract health. The results of the study are published online today in menopauseThe journal of Menopause Society.

When most people think about menopause, the most common symptoms that come to mind are hot flashes and night sweats. There was certainly no lack of research studies and advertising for these topics. Even if the term Genitary syndrome of menopause was first shaped by the menopause Society (formerly North American menopause society) and the international society for the examination of the sexual health of women, a large part of the focus on genital symptoms such as painful sexual intercourse and vaginal drought.

Over the years, much less research on the effects of menopause in the urine has been carried out. For this reason, a new study focused on identifying the connection between the menopausal status and hormone consumption with bladder health and the symptoms of the lower urinary tract. The results of this survey were published in the article “Association of the Menopaus estate and hormone consumption with bladder health and lower urinary tract symptoms in US women: Results from the increase in the health study”.

The study included more than 3,000 women who were classified as pre -menopausal, perimenopause or postmenopausal. The study not only brought to light a few new results, but also confirmed a number of earlier results, including the fact that bladder health is typically deteriorated with age, as well as the risk of incontinence and infections. In addition, hormone use has shown mixed results when it comes to urine symptoms. The use of the systemic hormone is specifically associated with a stronger incidence of incontinence in women after menopause, while localized hormone therapy with low-dose hormone therapy leads to improvements in genitourin symptoms and urinary tract infections.

One of the new findings from the study includes the fact that women explain hormones more often than perimenopausal or postmenopausal women before menopause. As a result of the use of hormones, they also had the slightest difference in bladder health. Perimenopausal and postmenopausal women experienced poorer bladder health and bladder function compared to women before menopause. In addition, the use of hormone therapy in postmenopausal women was specifically associated with poorer health of the bladder.

Based on the results of this large -scale study, the researchers came to the conclusion that the connection between the menopaus status and hormone consumption with the health of bladder health and the symptoms of the lower urinary tract is complex and multifaceted. They not only recommend additional research in this area, they also believe that there is a value to initiate educational programs before women enter menopause. Therefore, they recognize timely warning signs for effective intervention.

This study underlines the changes in bladder health in the entire menopause. The relationship between hormone therapy with the health of the blisters and the symptoms of the lower urinary tract is more complex and requires a nuanced and individual approach. “

Dr. Stephanie Faubion, medical director of the menopause Society